Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NC-NDArthritis research & therapy

Fc N-glycosylation heterogeneity of anti-MDA5 IgG is associated with interstitial lung disease severity via regulating FcγR/C1q signaling in MDA5 + dermatomyositis: a cross‑sectional study.

6 affiliations
  1. 1Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, P.R. China.
  2. 2Rheumatology and Immunology Laboratory, Jiading District Central Hospital Affiliated Shanghai University of Medicine &Health Sciences, Shanghai, P.R. China.
  3. 3Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, P.R. China.
  4. 4Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, P.R. China. [email protected].
  5. 5Rheumatology and Immunology Laboratory, Jiading District Central Hospital Affiliated Shanghai University of Medicine &Health Sciences, Shanghai, P.R. China. [email protected].
  6. 6Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, P.R. China. [email protected].

Abstract

Background

To characterize Fc N-glycosylation patterns of disease-specific IgG (DSIgG) in anti-MDA5-positive dermatomyositis (MDA5 + DM) and evaluate their associations with interstitial lung disease (ILD) severity.Methods

Eighty-four patients with MDA5 + DM and 60 healthy controls were enrolled. Disease-specific anti-MDA5 IgG glycopeptides were analyzed by UPLC-MS/MS. Associations between glycoform features and ILD severity were assessed using correlation analysis, ROC analysis, and logistic regression. Surface plasmon resonance and in vitro functional assays were used to compare glycoform-dependent engagement of FcγRIIa, FcγRIIIa, and C1q, as well as downstream ADCP, ADCC, CDC, and endothelial inflammatory responses.Results

Compared with controls, DSIgG1 from patients with MDA5 + DM showed higher fucosylation and lower sialylation. Severe ILD was associated with increased DSIgG1F and decreased DSIgG1S. In multivariable analysis, lower DSIgG1S remained independently associated with severe ILD (OR = 0.07, p = 0.0065), and DSIgG1S showed strong discriminatory performance for severe ILD (AUC = 0.9133). Functionally, G1S exhibited stronger FcγRIIa-related binding and phagocytic activity, whereas G1F displayed stronger FcγRIIIa and C1q binding, together with increased ADCC and CDC. In endothelial-cell experiments, the two glycoforms induced distinct inflammatory response patterns.Conclusion

Anti-MDA5 DSIgG Fc glycosylation is associated with ILD severity in MDA5 + DM. Distinct glycoforms exhibit differential FcγR/C1q-related effector profiles, supporting a potential role for Fc glycosylation heterogeneity in disease stratification and pathogenesis.

Related

  1. Staged multi-target therapy for anti-MDA5-positive dermatomyositis-associated rapidly progressive interstitial lung disease: a case report.
    Lvdan Zhang, Mengwen Jiao, Yan Hou +5
    Respiratory medicine case reportsPeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMC
  2. Candidate molecular endotypes and dynamic risk prediction in anti-MDA5-positive dermatomyositis-associated interstitial lung disease: a systematic scoping review
    Zhiwei Zuo, Jianguo Yang, Jianbin Li +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  3. Rituximab Combined With Azathioprine for Relapsed Anti-MDA5 Antibody-Positive Dermatomyositis With Interstitial Lung Disease: A Case Report.
    Hiroki Ozaki, Yuki Inoue
    Case reports in rheumatologyPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  4. Efficacy of early plasma exchange in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
    WEN Yanhua, WEN Peishan, DING Shuchang +2
    Zhongguo shuxue zazhiPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
  5. Longitudinal interferon signatures are associated with disease flare in dermatomyositis
    P. Liu, H. Chou, M. Jarry +4
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
BibTeX
@article{zhao2026nglycosylation,
  title = {{Fc N-glycosylation heterogeneity of anti-MDA5 IgG is associated with interstitial lung disease severity via regulating FcγR/C1q signaling in MDA5 + dermatomyositis: a cross‑sectional study.}},
  author = {Jiangfeng Zhao and Zhihua Yin and Li Guo and ZhiWei Chen and Yakai Fu and Haiting Yang and Shuang Ye and Kaiwen Wang and Haibo Zhou},
  journal = {Arthritis research \& therapy},
  year = {2026},
  month = aug,
  doi = {10.1186/s13075-026-03882-y},
  url = {https://europepmc.org/article/MED/43010084},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Fc N-glycosylation heterogeneity of anti-MDA5 IgG is associated with interstitial lung disease severity via regulating FcγR/C1q signaling in MDA5 + dermatomyositis: a cross‑sectional study.
AU  - Jiangfeng Zhao
AU  - Zhihua Yin
AU  - Li Guo
AU  - ZhiWei Chen
AU  - Yakai Fu
AU  - Haiting Yang
AU  - Shuang Ye
AU  - Kaiwen Wang
AU  - Haibo Zhou
PY  - 2026
DA  - 2026/08/15
JO  - Arthritis research & therapy
DO  - 10.1186/s13075-026-03882-y
UR  - https://europepmc.org/article/MED/43010084
AB  - Background  To characterize Fc N-glycosylation patterns of disease-specific IgG (DSIgG) in anti-MDA5-positive dermatomyositis (MDA5 + DM) and evaluate their associations with interstitial lung disease (ILD) severity.Methods  Eighty-four patients with MDA5 + DM and 60 healthy controls were enrolled. Disease-specific anti-MDA5 IgG glycopeptides were analyzed by UPLC-MS/MS. Associations between glycoform features and ILD severity were assessed using correlation analysis, ROC analysis, and logistic regression. Surface plasmon resonance and in vitro functional assays were used to compare glycoform-dependent engagement of FcγRIIa, FcγRIIIa, and C1q, as well as downstream ADCP, ADCC, CDC, and endothelial inflammatory responses.Results  Compared with controls, DSIgG1 from patients with MDA5 + DM showed higher fucosylation and lower sialylation. Severe ILD was associated with increased DSIgG1F and decreased DSIgG1S. In multivariable analysis, lower DSIgG1S remained independently associated with severe ILD (OR = 0.07, p = 0.0065), and DSIgG1S showed strong discriminatory performance for severe ILD (AUC = 0.9133). Functionally, G1S exhibited stronger FcγRIIa-related binding and phagocytic activity, whereas G1F displayed stronger FcγRIIIa and C1q binding, together with increased ADCC and CDC. In endothelial-cell experiments, the two glycoforms induced distinct inflammatory response patterns.Conclusion  Anti-MDA5 DSIgG Fc glycosylation is associated with ILD severity in MDA5 + DM. Distinct glycoforms exhibit differential FcγR/C1q-related effector profiles, supporting a potential role for Fc glycosylation heterogeneity in disease stratification and pathogenesis.
SN  - 1478-6354
SN  - 1478-6362
ER  -